Cotempla Xr-odt

  • ADHD

Cotempla Xr-odt Generic Name & Formulations

General Description

Methylphenidate 8.6mg, 17.3mg, 25.9mg; ext-rel orally disintegrating tabs.

Pharmacological Class

CNS stimulant.

How Supplied

Blister pack—30 (5×6)


Generic Availability


Cotempla Xr-odt Indications


Attention deficit hyperactivity disorder.

Cotempla Xr-odt Dosage and Administration

Adults and Children

<6yrs: not established. Place tab on tongue and allow it to disintegrate; do not chew or crush. 6–17yrs: Individualize. Initially 17.3mg once daily in the AM. May titrate in increments of 8.6–17.3mg weekly; max 51.8mg daily. Discontinue if no improvement seen after dose adjustment over 1 month.

Cotempla Xr-odt Contraindications


During or within 14 days of MAOIs.

Cotempla Xr-odt Boxed Warnings

Boxed Warning

Abuse and dependence.

Cotempla Xr-odt Warnings/Precautions


High potential for abuse and dependence; monitor. Increased risk of sudden death, stroke, and MI; assess for presence of cardiac disease before initiating. Avoid in known structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, other cardiac problems. Pre-existing psychotic disorder. Bipolar disorder. Screen for risk factors in developing a manic episode prior to initiating. Consider discontinuing if psychotic/manic symptoms occur. Peripheral vasculopathy, including Raynaud’s phenomenon; monitor for digital changes. Monitor growth (in children), BP, HR. Reduce dose or discontinue if paradoxical aggravation of symptoms occur. Reevaluate periodically. Pregnancy. Nursing mothers: monitor infants.

Cotempla Xr-odt Pharmacokinetics

See Literature

Cotempla Xr-odt Interactions


See Contraindications. Concomitant gastric pH modulators (eg, omeprazole, famotidine, sodium bicarbonate): not recommended. May decrease effectiveness of antihypertensive drugs (eg, K+-sparing or thiazide diuretics, CCBs, ACE inhibitors, ARBs, beta blockers, centrally acting alpha-2 receptor agonists); monitor and adjust dose of antihypertensives as needed. Concomitant risperidone may increase risk of extrapyramidal symptoms; monitor.

Cotempla Xr-odt Adverse Reactions

Adverse Reactions

Appetite decreased, insomnia, nausea, vomiting, dyspepsia, abdominal pain, weight decreased, anxiety, dizziness, irritability, affect lability, tachycardia, BP increased; priapism.

Cotempla Xr-odt Clinical Trials

See Literature

Cotempla Xr-odt Note


Register pregnant patients exposed to Cotempla XR-ODT by calling (866) 961-2388.

Cotempla Xr-odt Patient Counseling

See Literature